Lexeo Therapeutics, Inc. Common Stock (LXEO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 200.86M | 188.39M | 127.79M | 140.06M | 105.27M | 126.12M | 159.46M | 177.15M | 198.09M | 124.29M | 38.87M | 48.71M | 61.22M | 80.05M |
| Cash & Short-Term Investments | 71.77M | 181.77M | 41M | 132.89M | 99.83M | 121.52M | 157.02M | 174.98M | 195.06M | 121.47M | 35.45M | 45.54M | 58.85M | 77.33M |
| Cash Only | 71.77M | 63M | 41M | 35.48M | 28.91M | 35.01M | 157.02M | 174.98M | 195.06M | 121.47M | 35.45M | 45.54M | 58.85M | 77.33M |
| Short-Term Investments | 0 | 118.77M | 0 | 97.41M | 70.92M | 86.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 129.09M | 6.63M | 86.8M | 7.17M | 5.44M | 4.6M | 2.44M | 2.17M | 3.03M | 3K | 2.01M | 1.24M | 2.37M | 371K |
| Total Non-Current Assets | 49.49M | 80.3M | 16.05M | 36.01M | 20.42M | 20.82M | 14.41M | 14.86M | 15.12M | 15.51M | 15.85M | 16.23M | 16.6M | 17.03M |
| Property, Plant & Equipment | 8.35M | 8.86M | 9.41M | 9.76M | 10.13M | 10.56M | 11.15M | 11.61M | 11.86M | 12.26M | 12.6M | 12.97M | 13.34M | 13.78M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 34.51M | 71.44M | 0 | 23M | 7.04M | 7.01M | 0 | 0 | 0 | 0 | 0 | 0 | 3.26M | 0 |
| Other Non-Current Assets | 6.64M | 0 | 6.64M | 3.25M | 3.25M | 274K | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M | 0 | 3.25M |
| Total Assets | 250.36M | 268.69M | 143.84M | 176.07M | 125.69M | 146.94M | 173.87M | 192.01M | 213.21M | 139.81M | 54.72M | 64.94M | 77.82M | 97.08M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 99.19% | 82.85% | -17.27% | -8.3% | -41.05% | 5.1% | 217.71% | 195.67% | 173.96% | 44.02% | - | - | - | - |
| Total Current Liabilities | 14.19M | 16.81M | 17.27M | 31.59M | 30.82M | 22.85M | 26.82M | 18.88M | 21.63M | 17.24M | 23.04M | 13.66M | 13.69M | 14.35M |
| Accounts Payable | 3.33M | 4.86M | 4.66M | 20.02M | 11.98M | 6.42M | 8.44M | 5.76M | 4.3M | 3.79M | 2.65M | 2.37M | 3.91M | 2.68M |
| Days Payables Outstanding | 675.08 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 2.69M | 0 | 2.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.15M | 0 | 2.75M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.16M | 9.28M | 9.9M | 2.4M | 1.7M | 4.66M | 3.52M | 2.08M | 1.13M | 3.36M | 2M | 2.4M | 5.21M | 2.15M |
| Current Ratio | 14.16x | 11.21x | 7.40x | 4.43x | 3.42x | 5.52x | 5.95x | 9.38x | 9.16x | 7.21x | 1.69x | 3.57x | 4.47x | 5.58x |
| Quick Ratio | 14.16x | 11.21x | 7.40x | 4.43x | 3.42x | 5.52x | 5.95x | 9.38x | 9.16x | 7.21x | 1.69x | 3.57x | 4.47x | 5.58x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.67M | 5.21M | 5.74M | 6.26M | 6.75M | 7.25M | 7.72M | 8.18M | 8.63M | 9.03M | 194.5M | 194.9M | 10.28M | 195.68M |
| Long-Term Debt | 4.67M | 0 | 5.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 5.21M | 0 | 6.26M | 6.75M | 7.25M | 7.72M | 8.18M | 8.63M | 9.03M | 9.46M | 9.87M | 10.28M | 10.65M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 185.03M | 185.03M | 0 | 185.03M |
| Total Liabilities | 18.86M | 22.02M | 23.01M | 37.85M | 37.58M | 30.1M | 34.54M | 27.06M | 30.25M | 26.27M | 217.53M | 208.56M | 23.97M | 210.03M |
| Total Debt | 7.37M | 7.89M | 8.46M | 8.91M | 9.4M | 9.92M | 10.4M | 10.85M | 11.24M | 11.64M | 16.21M | 12.66M | 13.03M | 13.48M |
| Net Debt | -64.4M | -55.11M | -32.54M | -26.57M | -19.51M | -25.09M | -146.62M | -164.13M | -183.82M | -109.83M | -19.24M | -32.88M | -45.82M | -63.85M |
| Debt / Equity | 0.03x | 0.03x | 0.07x | 0.06x | 0.11x | 0.08x | 0.07x | 0.07x | 0.06x | 0.10x | - | - | 0.24x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1313.71x | -835.76x | -246.35x | -441.42x | -815.40x | -863.13x | -841.54x | -605.80x | -585.00x | -282.74x | -385.69x | -252.60x | -372.14x | -268.94x |
| Total Equity | 231.5M | 246.67M | 120.83M | 138.22M | 88.11M | 116.84M | 139.33M | 164.95M | 182.95M | 113.53M | -162.81M | -143.62M | 53.85M | -112.95M |
| Equity Growth % | 162.72% | 111.11% | -13.27% | -16.21% | -51.84% | 2.91% | 185.58% | 214.85% | 239.73% | 200.51% | - | - | - | - |
| Book Value per Share | 2.85 | 3.23 | 1.98 | 3.17 | 2.66 | 3.53 | 4.21 | 5.00 | 6.54 | 4.16 | -6.47 | -5.71 | 2.14 | -4.49 |
| Total Shareholders' Equity | 231.5M | 246.67M | 120.83M | 138.22M | 88.11M | 116.84M | 139.33M | 164.95M | 182.95M | 113.53M | -162.81M | -143.62M | 53.85M | -112.95M |
| Common Stock | 7K | 7K | 5K | 5K | 3K | 3K | 3K | 3K | 3K | 3K | 0 | 2K | 1.71K | 0 |
| Retained Earnings | -400.33M | -380.13M | -359.21M | -338.93M | -312.83M | -280.17M | -254.25M | -224.76M | -203.52M | -181.84M | -167.65M | -147.54M | -134.1M | -115.45M |
| Treasury Stock | 0 | -17K | 0 | -17K | -17K | -17K | -13K | -13K | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -142K | 188K | 89K | -13K | -54K | -103K | 0 | 0 | 0 | 0 | 0 | -185.03M | -1.71K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |